Infusion-related risks associated with chemotherapy
CPD Previous     Next

Infusion-related risks associated with chemotherapy

Elizabeth Gallimore Oncology research practitioner, Clatterbridge Cancer Centre, Merseyside, England

This article provides a comprehensive overview of the risks associated with the administration of chemotherapy, monoclonal antibodies and targeted or biological therapies in the management of solid tumours. The main physiological actions of these agents are discussed, with reference to the immediate infusion-related side effects and complications that may arise from an extravasation injury. The article focuses on the identification and early recognition of these risk factors to implement preventive measures and appropriate management strategies.

Nursing Standard. 30, 25, 51-60. doi: 10.7748/ns.30.25.51.s48


Peer review

All articles are subject to external double-blind peer review and checked for plagiarism using automated software.

Received: 29 May 2015

Accepted: 07 October 2015

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to and the Nursing Standard app
  • The monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now